Literature DB >> 8449820

Southernmost carriers of HTLV-I/II in the world.

L Cartier1, F Araya, J L Castillo, V Zaninovic, M Hayami, T Miura, J Imai, S Sonoda, H Shiraki, K Miyamoto.   

Abstract

To clarify the real distribution of HTLV-I and -II carriers among indigenous people in central and South America, blood samples collected from indigenous people in isolated regions of Southern Chile were examined. Among 199 inhabitants from Chiloe Island and Pitrufquen town, three cases (1.5%) showed positive anti-HTLV-I antibodies. Two out of the three (82-year-old male and 58-year-old female) reacted to HTLV-II-specific Gag and/or Env proteins but not to HTLV-I-specific ones. The latter case was confirmed as an HTLV-II carrier by polymerase chain reaction test.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449820      PMCID: PMC5919034          DOI: 10.1111/j.1349-7006.1993.tb02774.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  10 in total

1.  High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.

Authors:  H Lee; P Swanson; V S Shorty; J A Zack; J D Rosenblatt; I S Chen
Journal:  Science       Date:  1989-04-28       Impact factor: 47.728

2.  HTLV-II in patients with HTLV-I-associated myelopathy.

Authors:  J Kira; Y Koyanagi; T Hamakado; Y Itoyama; N Yamamoto; I Goto
Journal:  Lancet       Date:  1991-07-06       Impact factor: 79.321

3.  Lack of anti-HTLV-II seropositivity in HTLV-I-associated myelopathy and adult T-cell leukaemia.

Authors:  T Kiyokawa; K Yamaguchi; Y Nishimura; K Yoshiki; K Takatsuki
Journal:  Lancet       Date:  1991-08-17       Impact factor: 79.321

4.  Serological discrimination between HTLV-I and HTLV-II antibodies by ELISA using synthetic peptides as antigens.

Authors:  Y Washitani; N Kuroda; H Shiraki; Y Nishimura; K Yamaguchi; K Takatsuki; L P Fernando; C T Fang; H Kiyokawa; Y Maeda
Journal:  Int J Cancer       Date:  1991-09-09       Impact factor: 7.396

5.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

6.  Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama.

Authors:  M D Lairmore; S Jacobson; F Gracia; B K De; L Castillo; M Larreategui; B D Roberts; P H Levine; W A Blattner; J E Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

7.  A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.

Authors:  V S Kalyanaraman; M G Sarngadharan; M Robert-Guroff; I Miyoshi; D Golde; R C Gallo
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

8.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

Authors:  M Seiki; S Hattori; Y Hirayama; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

9.  Transformation of CD8+ T-cells producing a strong cytopathic effect on CD4+ T-cells through syncytium formation by HTLV-II.

Authors:  K Miyamoto; T Kamiya; J Minowada; N Tomita; K Kitajima
Journal:  Jpn J Cancer Res       Date:  1991-11

10.  Antibody to HTLV-I in indigenous inhabitants of the Andes and Amazon regions in Colombia.

Authors:  T Zamora; V Zaninovic; M Kajiwara; H Komoda; M Hayami; K Tajima
Journal:  Jpn J Cancer Res       Date:  1990-08
  10 in total
  10 in total

1.  HTLV-I from Iranian Mashhadi Jews in Israel is phylogenetically related to that of Japan, India, and South America rather than to that of Africa and Melanesia.

Authors:  M Yamashita; A Achiron; T Miura; J Takehisa; E Ido; T Igarashi; K Ibuki; M Osame; S Sonoda; E Melamed
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

2.  Seroprevalence of human T-cell lymphotropic virus type 1 and 2 in blood donors from the regional hospital of Valdivia, Chile.

Authors:  Luis Chandía; Cristina Sotomayor; Sylvia Ordenes; Pilar Salas; Maritza Navarrete; Mauricio Lopez; Carola Otth
Journal:  Med Microbiol Immunol       Date:  2010-08-13       Impact factor: 3.402

3.  Molecular phylogeny of human T-cell leukemia virus type I and II of Amerindians in Colombia and Chile.

Authors:  T Miura; M Yamashita; V Zaninovic; L Cartier; J Takehisa; T Igarashi; E Ido; T Fujiyoshi; S Sonoda; K Tajima; M Hayami
Journal:  J Mol Evol       Date:  1997       Impact factor: 2.395

4.  Human T-lymphotropic virus type 1 in coastal natives of British Columbia: phylogenetic affinities and possible origins.

Authors:  F J Picard; M B Coulthart; J Oger; E E King; S Kim; J Arp; G P Rice; G A Dekaban
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background.

Authors:  T Miura; T Fukunaga; T Igarashi; M Yamashita; E Ido; S Funahashi; T Ishida; K Washio; S Ueda; K Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

6.  Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2.

Authors:  N Eiraku; P Novoa; M da Costa Ferreira; C Monken; R Ishak; O da Costa Ferreira; S W Zhu; R Lorenco; M Ishak; V Azvedo; J Guerreiro; M P de Oliveira; P Loureiro; N Hammerschlak; S Ijichi; W M Hall
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

Review 7.  Origin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the Americas.

Authors:  Arthur Paiva; Jorge Casseb
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jan-Feb       Impact factor: 1.846

8.  Prevalence and phylogenetic analysis of HTLV-I isolates in Cameroon, including those of the Baka Pygmy.

Authors:  I Mboudjeka; L Zekeng; M Yamashita; J Takehisa; E Ido; T Miura; S Ohkura; M Ikeda; L Kaptue; M Hayami
Journal:  Jpn J Cancer Res       Date:  1997-07

Review 9.  Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL).

Authors:  Sanaz Ahmadi Ghezeldasht; Abbas Shirdel; Mohammad Ali Assarehzadegan; Tahereh Hassannia; Hosian Rahimi; Rahele Miri; S A Rahim Rezaee
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

10.  Detection of HTLV-II-seropositive blood donors in South Vietnam but not in North Vietnam.

Authors:  S Yamamoto; S Nakata; T Nakasone; T Chosa; P Song; D D Duc; B Hien; N X Quang; T N Trinh; T Ono
Journal:  Jpn J Cancer Res       Date:  1994-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.